Pharmacokinetics of midazolam in sevoflurane-anesthetized cats

ObjectiveTo estimate the pharmacokinetics of midazolam and 1-hydroxymidazolam after midazolam administration as an intravenous bolus in sevoflurane-anesthetized cats.Study designProspective pharmacokinetic study.AnimalsA group of six healthy adult, female domestic cats.MethodsAnesthesia was induced and maintained with sevoflurane. After 30 minutes of anesthetic equilibration, cats were administered midazolam (0.3 mg kg^–1) over 15 seconds. Venous blood was collected at 0, 1, 2, 4, 8, 15, 30, 45, 90, 180 and 360 minutes after administration. Plasma concentrations for midazolam and 1-hydroxymidazolam were measured using high-pressure liquid chromatography. The heart rate (HR), respiratory rate (f_R), rectal temperature, noninvasive mean arterial pressure (MAP) and end-tidal carbon dioxide (Pe′CO₂) were recorded at 5 minute intervals. Population compartment models were fitted to the time–plasma midazolam and 1-hydroxymidazolam concentrations using nonlinear mixed effect modeling.ResultsThe pharmacokinetic model was fitted to the data from five cats, as 1-hydroxymidazolam was not detected in one cat. A five-compartment model best fitted the data. Typical values (% interindividual variability where estimated) for the volumes of distribution for midazolam (three compartments) and hydroxymidazolam (two compartments) were 117 (14), 286 (10), 705 (14), 53 (36) and 334 mL kg^–1, respectively. Midazolam clearance to 1-hydroxymidazolam, midazolam fast and slow intercompartmental clearances, 1-hydroxymidazolam clearance and 1-hydroxymidazolam intercompartment clearance were 18.3, 63.5 (15), 22.1 (8), 1.7 (67) and 3.8 mL minute^–1 kg^–1, respectively. No significant changes in HR, MAP, f_R or Pe′CO₂ were observed following midazolam administration.Conclusion and clinical relevanceIn sevoflurane-anesthetized cats, a five-compartment model best fitted the midazolam pharamacokinetic profile. There was a high interindividual variability in the plasma 1-hydroxymidazolam concentrations, and this metabolite had a low clearance and persisted in the plasma for longer than the parent drug. Midazolam administration did not result in clinically significant changes in physiologic variables.     

日粮中添加不同比例的牧站1号王草益生菌发酵饲料对黑猪生产性能及养殖效益的影响

旨在研究5种比例的牧站1号王草益生菌发酵饲料对黑猪生产性能及养殖效益的影响。选择体重相近、健康状况良好的二元杂黑猪180头,随机分为6组,每组3次重复,每个重复10头。对照组饲喂基础日粮,试验Ⅰ组、Ⅱ组、Ⅲ组、Ⅳ组、Ⅴ组分别在基础日粮中添加10%、20%、30%、40%、50%牧站1号王草益生菌发酵饲料。饲喂试验预试期7 d,正试期60 d,计算并比较各组试验猪平均日增重、平均日采食量、腹泻率、屠宰率及养殖毛利润。试验结果表明：试验组与对照组比较,Ⅲ组试验猪平均日增重差异不显著（P>0.05）,其他试验组试验猪平均日增重差异显著（P<0.05）,最高为Ⅱ组（865.24 g/头）,高于对照组23.24%,其次是Ⅰ组（839.33 g/头）,高于对照组19.55%,最低为Ⅴ组（552.51 g/头）,低于对照组21.31%;平均日采食量最大为Ⅴ组（3.35 kg/头）,最小的为对照组（2.30 kg/头）,各试验组与对照组比较,差异显著（P<0.05）;屠宰率方面,Ⅰ组、Ⅱ组差异不显著（P>0.05）,Ⅲ组、Ⅳ组、Ⅴ组差异显著（P<0.05）,屠宰率随着牧站1号王草益生菌发酵饲料添加量的增加呈降低趋势,最高为对照组,最低为Ⅴ组;毛利润最高的为Ⅱ组（21 259.0元）,最低的为Ⅴ组（10 325.7元）。育肥黑猪日粮中添加 20%牧站1号王草益生菌发酵饲料生产性能及经济指标影响效果最佳。     

鸡贫血因子病的血液病理学变化

本实验用鸡贫血病毒感染１日龄健康ＡＡ雏鸡，以未感染雏鸡为对照，在感染后７、１４、２８、３５、４２日龄检测其外周血液各种血细胞数量，血红蛋白含量，红细胞压积，红细胞平均体积，红细胞平均血红蛋白量、红细胞平均血红蛋白浓度；骨髓红系祖细胞、粒单系祖细胞（ＣＵＦ－ＧＭ）、基质成纤维祖细胞（ＣＦＵ－Ｆ）的增殖功能；血清因子和胞腺集落刺激因子（ＣＳＦ）对造血祖细胞增殖功能的影响；骨髓造血细胞分化功能；骨髓造血     

MDCC—MSB1培养基上清液中DNA活性的定性研究

将 Ｍ Ｄ Ｃ Ｃ Ｍ Ｓ Ｂ１ ４８ 小时培养物 １０００ｒ／ｍ ｉｎ 离心的上清液分别用 Ｒ Ｎ Ａ 酶、 Ｄ Ｎ Ａ 酶和蛋白酶 Ｋ 处理后,进行体外试验。结果表明,只有 Ｄ Ｎ Ａ 酶处理后的上清液失去了体外抑制 Ｍ Ｄ Ｖ“８１４”增殖的作用。将该上清液 １００００ｒ／ｍ ｉｎ 离心所得的沉淀分别用上述酶处理后进行体内试验。结果表明,只有 Ｄ Ｎ Ａ 酶处理的样品失去了体内促进 Ｍ Ｄ Ｖ 京１ 株致瘤的作用。同时,电泳分析结果证明,该上清液中确实存在 Ｄ Ｎ Ａ。     

Leukocyte differentiation antigens in canine cutaneous and oral plasmacytomas

Seventeen cutaneous and oral tumours with light microscopic features of plasmacytomas from 16 dogs were studied. Clinically, most neoplasms were benign, although three recurred after excision and three were locally invasive. Tumours most often arose on the pinnae, digits, gingiva, and inguinal regions near areas of chronic inflammation and exhibited variable degrees of plasmacytic differentiation microscopically. Diagnosis of plasmacytoma was confirmed in paraffin-embedded tissues with a panel of leukocyte differentiation antigen markers that included cross-reactive antibodies for Mb-1 (CD79a), CD3, and vimentin and canine-specific antibodies for CD45RA and CD18. Immunoreactivity for Mb-1 and CD45RA, including staining of multinucleate cells and cells with karyomegaly, confirmed a B-cell origin of neoplasms, while staining for CD3 and CD18 revealed an extensive network of infiltrative T-cells and dendritic cells in tumours suggestive of a directed immune response. These findings (i) demonstrate the value of using a panel of antibodies for leukocyte antigens to differentiate plasmacytomas from other cutaneous and oral round cell tumours, and (ii) suggest that immune recognition and responsiveness within tumours may play a role in the behaviour of plasmacytomas in dogs by affecting tumour cell growth and differentiation.     

口蹄疫病毒VP1基因密码子偏好性分析

VP1蛋白是口蹄疫病毒(FMDV)的主要结构蛋白,可诱导机体产生中和抗体以及激发保护性免疫应答。为探究VP1基因密码子偏好性,筛选出其最佳体外表达系统,使用Visual Gene Developer、CodonW、GraphPad Prism等软件,对VP1基因进行密码子偏好性分析,同时将VP1基因密码子使用频率与大肠杆菌、毕赤酵母、昆虫杆状病毒和哺乳动物细胞表达系统作了比较。结果显示,VP1基因的CAI为0.21,ENC为55.43,GC3S为65.26%,表明该基因密码子使用偏好较弱并且密码子偏好以G/C碱基结尾。结合VP1基因与各表达系统密码子使用频率比值,发现其与昆虫杆状病毒表达系统频率比值差异最小且CAI最大,因此推断昆虫杆状病毒表达系统是FMDV VP1基因最适体外表达系统。本研究为FMDV亚单位疫苗研制等提供了技术基础。     

乳牛口服过量维生素A对维生素D3及钙磷代谢的影响

从北京郊区某农场选取１０头健康成年黑白花乳牛，随机分为试验（５头，每周每头口服维生素Ａ１００万单位）和对照（５头，不作任何处理）两组。８周以后检测发现，试验组血清钙和无机磷水平呈下降趋势；尾椎骨皮质变薄，密度下降，呈现骨质吸收现象；血清碱性磷酸酶显著下降（Ｐ＜０．０５）；其活性代谢产物２５－羟维生素Ｄ３（２５－ＯＨ－Ｄ３）极显著下降（Ｐ＜０．０１）；１，２５－二羟维生素Ｄ３［１，２５－（ＯＨ）２－     

多型FMDV VP1表位嵌入型载体pMG-SLPMultiVP1的构建及其表达产物鉴定

构建出表达载体pMG-SLPMultiVP1,并对其进行双酶切鉴定及PCR鉴定。将阳性重组质粒转入到发酵乳杆菌中进行表达,并对表达产物进行SDS-PAGE、Western blot和IFAT鉴定。多型FMDV VP1表位嵌入的SLPMultiVP1融合基因成功克隆入穿梭质粒pMG36e中,其表达产物大小约为35ku,部分表达产物位于发酵乳杆菌表面。成功构建了一个乳杆菌嵌入型表达载体pMG-SLPMultiVP1,为以发酵乳杆菌为活菌载体的表位疫苗研究奠定了基础。     

影响棕色脂肪组织产热活性因素的研究进展

全球性肥胖流行问题愈发严峻,而脂肪组织本身可能是解决这个问题的关键。人和哺乳动物体内存在两种脂肪组织,发挥着截然相反的作用。与白色脂肪组织存储机体过剩的能量不同,棕色脂肪组织中存在独特的解偶联蛋白,能将脂肪酸氧化磷酸化,释放热能,增加能量消耗。因此,通过激活棕色脂肪组织产热,加速体内储存的脂质氧化磷酸化,成为了一种新的预防和治疗肥胖的手段。论文阐述影响棕色脂肪产热活性的因素以及相关机制,旨在为肥胖的治疗提供新的思路和方向。